List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 529 studies with search of:   Australia, Western Australia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Completed Study to Compare the Efficacy and Safety of CC-5013 Vs. Placebo in Subjects With Metastatic Malignant Melanoma.
Conditions: Melanoma;   Neoplasm Metastasis
Intervention: Drug: CC-5013
22 Recruiting Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid;   Osteoarthritis
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
23 Active, not recruiting A Study to Assess the Efficacy, Safety,and Tolerability of CAT-354
Condition: Asthma
Interventions: Drug: CAT-354;   Drug: Placebo
24 Completed Can Resistance Enhance Selection of Treatment? (CREST)
Condition: HIV Infection
Intervention: Device: HIV drug resistance tests based upon genotype testing
25 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: PEP005
26 Completed Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Conditions: Bowel Dysfunction;   Constipation
Intervention: Drug: alvimopan
27 Active, not recruiting Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: lapatinib (GW572016)
28 Recruiting Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Placebo
29 Recruiting GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
Condition: Tumor Antigen-Positive Non-Small Cell Lung Cancer
Intervention: Biological: GSK1572932A Antigen-Specific Cancer Immunotherapeutic
30 Completed Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)
Condition: Hot Flashes
Interventions: Drug: Other: Placebo;   Drug: GSK232802;   Drug: PREMARIN
31 Active, not recruiting Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
Condition: Chronic Hepatitis C
Interventions: Drug: albumin interferon alfa-2b;   Drug: peginterferon alfa-2a;   Drug: Ribavirin
32 Completed A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Inhaled mannitol
33 Recruiting A Randomised, Open-Label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-Emtricitabine or Abacavir-Lamivudine: The STEAL Study
Condition: HIV Infections
Interventions: Drug: Emtricitabine 200mg – Tenofovir 300mg;   Drug: Abacavir 600mg – Lamivudine 300mg
34 Completed Safety and Efficacy of Bronchitol in Bronchiectasis
Condition: Bronchiectasis
Interventions: Drug: Mannitol;   Drug: placebo
35 Recruiting Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: PI-88 and dacarbazine;   Drug: dacarbazine or DTIC
36 Completed Metvix PDT in Patients With "High Risk" Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Procedure: Photodynamic therapy with Metvix 160 mg/g cream
37 Active, not recruiting Fixed Dose MMF Vs Concentration Controlled MMF After Renal Transplantation
Condition: De Novo Renal Transplant Recipient.
Intervention: Drug: Mycophenolate Mofetil
38 Active, not recruiting Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: pegylated interferon alfa;   Procedure: adjuvant therapy
39 Completed A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: rosiglitazone/metformin
40 Completed Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery
Condition: Venous Thrombosis
Interventions: Drug: PD 0348292;   Drug: Enoxaparin

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services